- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02737683
Heterogeneous Distribution of Health Literacy and Emotional State on Patients With Functional Dyspepsia.
Study Overview
Status
Conditions
Detailed Description
Health literacy can be defined as "ability for obtaining basic health information and understanding medical services." Within 10 years, healthy development and application of knowledge used in medical care and public health fields that have raised more attentions, many European countries set health knowledge as one of the main indicators for health care policy in the future. To promote behavior of self-care health for people, enhance the effective use of medical service , also reduce health care cost and unequally medical information.
Anxiety and depression are two common reactions when it comes to negative emotional states, which related to a body and caused a vicious cycle of disease. Some patients suffer from functional dyspepsia symptoms were diagnosed with anxiety or depression symptoms often ignore body care due to lack of health literacy. The purpose of this study is to investigate the distribution of functional dyspepsia patients with health literacy and emotional status, in order to provide more effective health education mode, thereby reducing the waste of medical resources, and promote patient health.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Ming Shun Wu, Dr
- Phone Number: 886970746512
- Email: mswu@tmu.edu.tw
Study Locations
-
-
-
Taipei, Taiwan, 116
- Recruiting
- WanFangH
-
Contact:
- Ming Shun Wu, Dr
- Phone Number: 886970746512
- Email: mswu@tmu.edu.tw
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients diagnosed with functional dyspepsia , can Self-reading and the self-administered questionnaire.
Exclusion Criteria:
- Due to physical illness, cognitive ability is limited and other factors can not were completed self-administered questionnaires.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Symptom diagnoses are based on Rome III criteria as diagnostic criteria
Time Frame: up to 10 months to collect data and perform an analysis
|
up to 10 months to collect data and perform an analysis
|
Collaborators and Investigators
Investigators
- Study Chair: Ming Shun Wu, Dr, Taipei Medical University WanFang Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- N201601022
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dyspepsia
-
King Chulalongkorn Memorial HospitalRecruiting
-
Wuhan Central HospitalNot yet recruiting
-
Dong-A ST Co., Ltd.Not yet recruitingFunctional DyspepsiaKorea, Republic of
-
Universitaire Ziekenhuizen KU LeuvenRecruiting
-
Universitaire Ziekenhuizen KU LeuvenRecruiting
-
Zeria PharmaceuticalRecruitingFunctional DyspepsiaJapan
-
Hong Kong Baptist UniversityXiyuan Hospital of China Academy of Chinese Medical SciencesRecruitingFunctional DyspepsiaHong Kong
-
Seoul National University HospitalCompletedFunctional DyspepsiaKorea, Republic of
-
Wonju Severance Christian HospitalCompletedFunctional DyspepsiaKorea, Republic of
-
Daewoong Pharmaceutical Co. LTD.CompletedFunctional DyspepsiaKorea, Republic of